Note: Ingredients listed on restricted chemical lists
EC/CAS
231-633-2/7664-38-2
Name of the chemical
phosphoric acid
Concentration
<0.1 25≤C≤100
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
<0.1 0.05≤C<100
General Information
Version
0.0/CA (eng
Revision date
2023-12-29
Product name
INTENSA
Icons in SDS
Company Information
company name
Sharda Cropchem Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
regn@shardaintl.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H331, H400
Hazard statements
Code
Statements
H331
Toxic if inhaled
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS06 GHS09
Signal word
Danger
Contains
Sulfentrazone
Hazard statements
H331 - Toxic if inhaled. H400 - Very toxic to aquatic life.
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P271 - Use only outdoors or in a well-ventilated area. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P391 - Collect spillage. P403+P233 - Store in a well-ventilated place. Keep container tightly closed. P405 - Store locked up. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Supplemental label elements
EUH208 - Contains 1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3-one(2634-33-5). May produce an allergic reaction. EUH401 - To avoid risks to human health and the environment, comply with the instructions for use.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
